Selvindos Paul B, Ho Yik-Hong
Department of Surgery, James Cook University, Townsville, Queensland, Australia.
Dis Colon Rectum. 2008 Nov;51(11):1710-1. doi: 10.1007/s10350-008-9322-4. Epub 2008 Aug 5.
Optimal treatment of mid to distal rectal cancers includes total mesorectal excision for oncologic clearance and, where reanastomosis is feasible, a colonic J-pouch-anal anastomosis improves bowel function. There is recent interest in performing an ultralow anterior resection laparoscopically. A technique is described that includes specimen extraction through the eventual routine defunctioning colostomy or ileostomy site.
Consecutive unselected patients who underwent laparoscopic ultralow anterior resection were recruited. Patients with adenocarcinoma underwent preoperative endorectal ultrasound to individualize for neoadjuvant chemoradiotherapy, based on local extent and lymph nodes seen. The operative procedures were as shown in the video. Posterior dissection along the "total mesorectal excision plane" included incision of Waldeyer's fascia. Bowel continuity was restored by an intracoporeal double-cross stapled colonic J-pouch-anal anastomosis, but where not possible a coloplasty with pull-through handsewn coloanal anastomosis was performed.
Laparoscopic ultralow anterior resection was performed on 55 patients (35 men; median age, 63 (range, 33-90) years) from March 2004 to October 2006. The median body mass index was 26.3 (19-38); 14 patients (25 percent) had a body mass index >30. Ten patients (18 percent) had an American Society of Anesthesiologists' classification of III. The indications were adenocarcinoma (n = 51), squamous-cell carcinoma of rectum (n = 1), dermoid tumor of mesorectum (n = 1), large villous adenoma (n = 1), and carcinoid with local lymph node metastases (n = 1). The adenocarcinomas were a median distance of 6 (3-12) cm from the anal verge. Neoadjuvant radiotherapy was given in 12 patients (24 percent) who had preoperative endoanal ultrasound findings of tumor extension beyond the muscularis propria and chemoradiotherapy in 7 (14 percent) of these patients where the tumor was more bulky and fixed. Laparoscopic ultralow anterior resection was completed at a median 180 (90-405) minutes, with 53.5 (2-2250) ml of blood loss, and the specimen was extracted through a 4.5 (3.5-11) cm wound. The latter included three cases (5 percent) that were converted. Significant adhesiolysis was required in 29 patients (52.7 percent) because of previous operations. The histologic grading or the adenocarcinoma patients were: Stage I, n = 14; Stage II, n = 23; Stage III, n = 11; Stage IV, n = 3. Of those who underwent curative resection (Stages I-III), the distal resection margin was 2.9 +/- 0.7 cm (mean +/- standard error) and the radial resection margins were at least 2 mm in all patients. The level of the coloanal anastomosis was a median 3.5 (0-4.5) cm from the anal verge; a coloanal pull-through anastomosis was required in one patient who had a distal cancer. The ileostomies functioned and patients tolerated free fluids at a median of two (1-9) days, and the median postoperative hospital stay was seven (3-22) days. At a median follow-up of 14 (2-33) months, none of the adenocarcinoma patients who had undergone curative resection had recurrences. Four patients (8 percent) had postoperative complications that required operative/invasive intervention (anatomotic leak n = 1, proximal bowel ischemia n = 1, port site hernia n = 1, pelvic collection n = 1). Four other patients had smaller pelvic collections that resolved with antibiotics; pelvic collections were associated with advanced stage of cancer (P = 0.047). Discharge was delayed by acute gastric distension in 11 patients; the latter was associated with poorer American Society of Anesthesiologists' risk classification (P = 0.035). Erectile dysfunction occurred in ten men, and this was associated with adjuvant chemoradiotherapy (P = 0.042). One patient (2 percent) had persistent urinary retention that required catheterization at latest follow-up. The ileostomy had been closed in 50 patients, and at last follow-up, the median stool frequency was two (1-8) bowel movements per day.
Laparoscopic ultralow anterior resection could be offered routinely and completed safely in Western populations, where obesity and adhesions from previous abdominal surgery is common. A laparoscopic technique readily allowed visual identification of the autonomic nerves in the abdomen over the aorta, which could then be followed down into the pelvis. If the pelvis was deep, inversion of the 30 degrees laparoscope in the "upside down" position fascilited incision of Waldeyer's fascia. This brought the rectum proximally and anteriorly, aiding with the laparoscopic stapler transection of the distal rectum, especially if the cancer was distal, the patient was obese, and the pelvis was narrow. Extraction of the specimen at the eventual defunctioning stoma site reduced the incisions required. Preoperative chemoradiotherapy may have a role in postoperative male sexual dysfunction. Further randomized, controlled studies that include assessing five-year cancer survival/recurrence, pelvic nerve dysfunction, and bowel function are needed before laparoscopic ultralow anterior resection becomes widely accepted.
中低位直肠癌的最佳治疗包括行全直肠系膜切除术以实现肿瘤学根治,并且在可行端端吻合的情况下,结肠J袋肛管吻合术可改善肠道功能。近期,人们对腹腔镜下超低位前切除术产生了兴趣。本文描述了一种技术,该技术包括通过最终常规的转流性结肠造口术或回肠造口术部位取出标本。
招募连续入选的接受腹腔镜超低位前切除术的患者。腺癌患者术前行直肠内超声检查,根据局部范围和所见淋巴结情况个体化制定新辅助放化疗方案。手术步骤如视频所示。沿“全直肠系膜切除平面”进行后方分离,包括切开Waldeyer筋膜。通过体内双吻合器结肠J袋肛管吻合术恢复肠道连续性,但在无法进行该操作时,则行结肠成形术并经腹拖出手工缝合结肠肛管吻合术。
2004年3月至2006年10月,对55例患者(35例男性;中位年龄63岁(范围33 - 90岁))实施了腹腔镜超低位前切除术。中位体重指数为26.3(19 - 38);14例患者(25%)体重指数>30。10例患者(18%)美国麻醉医师协会分级为III级。手术适应证包括腺癌(n = 51)、直肠鳞状细胞癌(n = 1)、直肠系膜皮样囊肿(n = 1)、大绒毛状腺瘤(n = 1)以及伴有局部淋巴结转移的类癌(n = 1)。腺癌距肛缘的中位距离为6(3 - 12)cm。12例患者(24%)术前行直肠内超声检查发现肿瘤侵犯超过固有肌层,其中7例(14%)肿瘤体积较大且固定的患者接受了新辅助放化疗。腹腔镜超低位前切除术的中位手术时间为180(90 - 405)分钟,失血53.5(2 - 2250)ml,标本通过4.5(3.5 - 11)cm的切口取出。其中3例(5%)中转开腹。29例患者(52.7%)因既往手术需要进行广泛的粘连松解。腺癌患者的组织学分级为:I期,n = 14;II期,n = 23;III期,n = 11;IV期,n = 3。接受根治性切除(I - III期)的患者,远端切缘为2.9±0.7 cm(均值±标准误),所有患者的径向切缘至少为2 mm。结肠肛管吻合口距肛缘的中位距离为3.5(0 - 4.5)cm;1例远端癌患者需要行结肠拖出式吻合术。回肠造口功能良好,患者在中位时间为2(1 - 9)天开始耐受流食,术后中位住院时间为7(3 - 22)天。中位随访14(2 - 33)个月,接受根治性切除的腺癌患者均无复发。4例患者(8%)出现需要手术/侵入性干预的术后并发症(吻合口漏1例、近端肠缺血1例、切口疝1例、盆腔积液1例)。另外4例患者有较小的盆腔积液,经抗生素治疗后缓解;盆腔积液与癌症晚期相关(P = 0.047)。11例患者因急性胃扩张导致出院延迟;后者与美国麻醉医师协会风险分级较差相关(P = 0.035)。10例男性出现勃起功能障碍,这与辅助放化疗相关(P = 0.042)。1例患者(2%)在最后随访时仍有持续性尿潴留,需要留置导尿管。50例患者的回肠造口已关闭,在最后随访时,中位排便频率为每天2(1 - 8)次。
在肥胖和既往腹部手术导致粘连常见的西方人群中,腹腔镜超低位前切除术可常规开展且安全完成。腹腔镜技术便于在腹部主动脉上方直视辨认自主神经,然后可追踪至盆腔。如果盆腔较深,将30度腹腔镜倒置成“头下脚上”位有助于切开Waldeyer筋膜。这使直肠向近端和前方移位,有助于腹腔镜吻合器横断远端直肠,尤其是在癌症位于远端、患者肥胖且盆腔狭窄的情况下。在最终的转流造口部位取出标本减少了所需的切口。术前放化疗可能与术后男性性功能障碍有关。在腹腔镜超低位前切除术被广泛接受之前,需要进一步开展随机对照研究,评估五年癌症生存率/复发率、盆腔神经功能障碍和肠道功能。